ICM Clinical Refresher Course
Returning to the clinical coalface after a prolonged absence is inherently challenging. The good thing is there are courses that can help you get back in the swing of things.
Category Intensive Care
Mastering Intensive Care 082 with Will Bonavia
Mastering Intensive Care 082 with Will Bonavia. An ICU trainee’s perspective on learning, culture and wellbeing
Network Five: Critical Care
Network Five Emergency Medicine Journal Club Episode 21 - Critical Care reviewing papers on cardiogenic shock, intravenous fluids in sepsis and lung protective ventilation strategies.
Mastering Intensive Care 080 with Tub Worthley
Mastering Intensive Care 080 with Tub Worthley. Dr. Lindsay Ian Grant "Tub" Worthley worked as an intensive care medical specialist at the Royal Adelaide hospital ICU between 1971 and 1991
Mastering Intensive Care 079 Run Larapinta
Mastering Intensive Care 079 Run Larapinta with fellow intensivist Ed Litton who shares his passion for adventure and ultra-endurance exercise.
Mastering Intensive Care 078 with Chris Nickson
Modern & innovative clinician education. Mastering Intensive Care 078 with Chris Nickson Intensivist and ECMO specialist
Desmopressin (DDAVP)
Desmopressin (DDAVP) is a drug used primarily for diabetes insipidus, haemophilia type A, and von Willebrand's disease.
Clevidipine
Clevidipine is a drug used as an infusion for severe hypertension or patients who require narrow blood pressure parameters.
Ventilation: Volume vs Pressure Control
Medmastery Mechanical Ventilation Essentials course, explore why volume control is the preferred initial breath type of ventilation.
Ventilation: AC/SIMV modes
Medmastery Mechanical Ventilation Essentials course - assist control (AC) and synchronized intermittent mandatory ventilation (SIMV)
Drug Infusion Doses
A summary of commonly used drug infusions and their dosing and preparation for use in critical care (ICU / Anaesthethics / Emergency)
COVID STEROID 2 and the non-statistically significant result
COVID STEROID 2 was recently published in JAMA. How do you interpret the study findings given the non-statistically significant primary outcome?